Scarica l'app Stockscreener
3.07
1.15%
0.035
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.035
Aprire:
$3.03
Volume 24 ore:
169.61K
Relative Volume:
0.97
Capitalizzazione di mercato:
$122.19M
Reddito:
$2.70M
Utile/perdita netta:
$5.53M
Rapporto P/E:
27.91
EPS:
0.11
Flusso di cassa netto:
$-10.55M
1 W Prestazione:
+14.13%
1M Prestazione:
+24.29%
6M Prestazione:
+37.05%
1 anno Prestazione:
+23.29%
Intervallo 1D:
$3.00
$3.1999
Intervallo di 1 settimana:
$2.66
$3.1999
Portata 52W:
$1.82
$3.1999
Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile
Nome
Oramed Pharmaceuticals Inc
Settore
Industria
Telefono
646-844-1164
Indirizzo
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
Confronta ORMP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ORMP
Oramed Pharmaceuticals Inc
|
3.07 | 120.80M | 2.70M | 5.53M | -10.55M | 0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-01-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-02-18 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-04-20 | Iniziato | Canaccord Genuity | Buy |
| 2021-02-09 | Iniziato | National Securities | Buy |
| 2020-12-03 | Iniziato | Alliance Global Partners | Buy |
| 2020-03-11 | Iniziato | Aegis Capital | Buy |
| 2019-09-11 | Iniziato | Ladenburg Thalmann | Buy |
| 2017-12-11 | Ripresa | B. Riley FBR, Inc. | Buy |
| 2016-05-26 | Reiterato | FBR Capital | Outperform |
| 2015-12-01 | Reiterato | H.C. Wainwright | Buy |
| 2015-11-19 | Iniziato | FBR Capital | Outperform |
| 2015-04-13 | Ripresa | MLV & Co | Buy |
| 2014-01-30 | Reiterato | Aegis Capital | Buy |
| 2014-01-08 | Reiterato | Aegis Capital | Buy |
| 2014-01-08 | Iniziato | MLV & Co | Buy |
| 2013-12-03 | Iniziato | Aegis Capital | Buy |
Mostra tutto
Oramed Pharmaceuticals Inc Borsa (ORMP) Ultime notizie
How strong dollar benefits Oramed Pharmaceuticals Inc. (OJU1) stockJuly 2025 Drop Watch & Fast Entry High Yield Stock Tips - Newser
Why Oramed Pharmaceuticals Inc. stock appeals to analystsJobs Report & Free AI Powered Buy and Sell Recommendations - Newser
Will Oramed Pharmaceuticals Inc. stock gain from strong economyJuly 2025 Selloffs & Free Fast Gain Swing Trade Alerts - Newser
Will Oramed Pharmaceuticals Inc. (OJU1) stock maintain strong growthRate Hike & Community Verified Trade Signals - Newser
How Oramed Pharmaceuticals Inc. (OJU1) stock correlates with oil markets2025 Short Interest & Stock Market Timing Techniques - Newser
How Oramed Pharmaceuticals Inc. (OJU1) stock valuation compares with sectorJuly 2025 Final Week & Weekly Setup with High ROI Potential - Newser
Is Oramed Pharmaceuticals Inc. (OJU1) stock a buy on weakness2025 Growth vs Value & Technical Pattern Recognition Alerts - Newser
Is Oramed Pharmaceuticals Inc a good long term investmentSector Performance Review & High Yield Trading Growth - earlytimes.in
Is Oramed Pharmaceuticals Inc. (OJU1) stock suitable for passive index funds2025 Key Lessons & Detailed Earnings Play Strategies - BỘ NỘI VỤ
Why Oramed Pharmaceuticals Inc. stock could outperform in 2025CPI Data & Verified Entry Point Detection - BỘ NỘI VỤ
MSN Money - MSN
ORMP: Advancing Clinical Activities, Generating Gains From Investment Portfolio, New Rights Plan Adopted - Yahoo Finance
Oramed Pharm Repurchases Shares, Ends Joint Venture - MSN
There Are Some Holes In Oramed Pharmaceuticals' (NASDAQ:ORMP) Solid Earnings Release - Yahoo Finance
Oramed Pharmaceuticals' (NASDAQ:ORMP) Profits May Be Overstating Its True Earnings Potential - simplywall.st
Why Oramed Pharmaceuticals Inc. (OJU1) stock attracts HNW investorsTrade Analysis Report & Expert Approved Momentum Ideas - newser.com
What market sentiment indicators show for Oramed Pharmaceuticals Inc. (OJU1) stockMarket Rally & High Accuracy Trade Signal Alerts - newser.com
Is Oramed Pharmaceuticals Inc. stock overvalued by current metricsBull Run & Consistent Return Strategy Ideas - newser.com
Head-To-Head Comparison: Oramed Pharmaceuticals (NASDAQ:ORMP) and Zimmer Biomet (NYSE:ZBH) - Defense World
How Oramed Pharmaceuticals Inc. (OJU1) stock performs during market turbulence2025 Retail Activity & Weekly High Return Stock Opportunities - newser.com
Is Oramed Pharmaceuticals Inc. (OJU1) stock vulnerable to rate hikes2025 Top Decliners & AI Driven Price Predictions - newser.com
Is Oramed Pharmaceuticals Inc. (OJU1) stock a fit for income portfoliosQuarterly Risk Review & Weekly Chart Analysis and Trade Guides - newser.com
Is Oramed Pharmaceuticals Inc. stock a top pick in earnings seasonQuarterly Market Summary & Stepwise Swing Trade Plans - newser.com
What recovery options are there for Oramed Pharmaceuticals Inc.Market Performance Summary & AI Powered Market Entry Ideas - newser.com
Can technical indicators confirm Oramed Pharmaceuticals Inc.’s reversal2025 Short Interest & Free Growth Oriented Trading Recommendations - newser.com
Tools to assess Oramed Pharmaceuticals Inc.’s risk profile2025 Historical Comparison & Accurate Intraday Trade Tips - newser.com
Forecasting Oramed Pharmaceuticals Inc. price range with options dataCPI Data & High Return Stock Watch Alerts - newser.com
What sentiment indicators say about Oramed Pharmaceuticals Inc. stock2025 Geopolitical Influence & Daily Risk Controlled Trade Plans - newser.com
Published on: 2025-11-19 00:19:35 - newser.com
Published on: 2025-11-22 06:20:56 - earlytimes.in
Oramed Pharmaceuticals Inc Azioni (ORMP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.08%
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):